Allan Reine

CIK 1714023 · Chief Executive Officer · last filed 2026-02-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$571.7K

Companies

3

Total Filings

18

Lifetime Open-Market Net

$460.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRME Chief Executive Officer 125,000 $2.77 $346.9K $147.2K 9 2026-02-27
FHTX Chief Financial Officer 53,784 $4.18 $224.8K $0 5 2024-01-17
PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Chief Financial Officer 45,000 $13.60 $612.0K $313.4K 4 2019-02-28

Recent Filings · Page 2 of 2

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-01-30 FHTX Grant (A) $0 EDGAR
2022-01-28 FHTX Grant (A) $0 EDGAR
2021-08-11 FHTX Exer (M) +26,892 $100.0K EDGAR
2021-02-01 FHTX Grant (A) $0 EDGAR
2019-02-28 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) $0 EDGAR
2018-02-26 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) $0 EDGAR
2017-08-17 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Buy (P) +65,000 $313.4K EDGAR
2017-08-11 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) $0 EDGAR
Showing 1118 of 18
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.